Log In
BCIQ
Print this Print this
 

cis-UCA Eye Drops

  Manage Alerts
Collapse Summary General Information
Company Herantis Pharma plc
DescriptionViscous formulation of cis-urocanic acid, a serotonin (5-HT2A) receptor agonist
Molecular Target Serotonin (5-HT2A) receptor
Mechanism of ActionUndisclosed
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDry eye
Indication DetailsTreat dry eye syndrome
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today